Develops nanotherapeutics for neurodegenerative diseases like ALS, MS, and Parkinson's.
Jun 2026Revenue $197K/yrExpenses $20.7M/yr
No trendCash runway ≈ 7 months from Jun 2026
Figures by year
When will Clene be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $197K and expenses $20.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $200K | $23.3M | −$23.1M |
| Dec 2024 | $342K | $33.4M | −$33.1M |
| Dec 2023 | $654K | $41.2M | −$40.5M |
| Dec 2022 | $473K | $48.9M | −$48.4M |
| Dec 2021 | $723K | $50.7M | −$50.0M |
| Dec 2020 | $206K | $20.4M | −$20.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.